Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo

Background: Geniposide and chlorogenic acid are the major active ingredients in Yinchenhao Decoction and are widely used as herbal medicines in Asia. This study further assessed their effects on improvement of non-alcoholic steatohepatitis (NASH) in a mouse model and explored the underlying molecula...

Full description

Bibliographic Details
Main Authors: Hongshan Li, Yingfei Xi, Xin Xin, Qin Feng, Yiyang Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1148737/full
_version_ 1827974857054224384
author Hongshan Li
Hongshan Li
Yingfei Xi
Xin Xin
Qin Feng
Yiyang Hu
author_facet Hongshan Li
Hongshan Li
Yingfei Xi
Xin Xin
Qin Feng
Yiyang Hu
author_sort Hongshan Li
collection DOAJ
description Background: Geniposide and chlorogenic acid are the major active ingredients in Yinchenhao Decoction and are widely used as herbal medicines in Asia. This study further assessed their effects on improvement of non-alcoholic steatohepatitis (NASH) in a mouse model and explored the underlying molecular events in vivo.Methods: Male C57BL/6 and farnesoid X receptor knockout (FXR−/−) mice were used to establish the NASH model and were treated with or without geniposide, chlorogenic acid, obeticholic acid (OCA), and antibiotics for assessment of the serum and tissue levels of various biochemical parameters, bile acid, DNA sequencing of bacterial 16S amplicon, protein expression, and histology.Results: The data showed that the combination of geniposide and chlorogenic acid (GC) reduced the levels of blood and liver lipids, serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST), and the liver tissue index in NASH mice. In addition, GC treatment improved the intestinal microbial disorders in the NASH mice as well as the intestinal and serum bile acid metabolism. At the gene level, GC induced FXR signaling, i.e., increased the expression of FXR, small heterodimer partner (SHP), and bile salt export pump (BSEP) in liver tissues and fibroblast growth factor 15 (FGF15) expression in the ileal tissues of NASH mice. However, antibiotics (ampicillin, neomycin, vancomycin, and tinidazole) in drinking water (ADW) reversed the effect of GC on NASH and altered the gut microbiota in NASH mice in vivo. Furthermore, GC treatment failed to improve NASH in the FXR−/− mouse NASH model in vivo, indicating that the effectiveness of GC treatment might be through FXR signaling activation.Conclusion: GC was able to alleviate NASH by improving the gut microbiome and activating FXR signaling; its effect was better than each individual agent alone.
first_indexed 2024-04-09T20:01:09Z
format Article
id doaj.art-a734333b73dc4c5e9e51c7ffa08728f5
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-09T20:01:09Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-a734333b73dc4c5e9e51c7ffa08728f52023-04-03T04:41:12ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-04-011410.3389/fphar.2023.11487371148737Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivoHongshan Li0Hongshan Li1Yingfei Xi2Xin Xin3Qin Feng4Yiyang Hu5Institute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaLiver Disease Department of Integrative Medicine, Ningbo No. 2 Hospital, Ningbo, Zhejiang, ChinaEndocrine Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang, ChinaInstitute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaBackground: Geniposide and chlorogenic acid are the major active ingredients in Yinchenhao Decoction and are widely used as herbal medicines in Asia. This study further assessed their effects on improvement of non-alcoholic steatohepatitis (NASH) in a mouse model and explored the underlying molecular events in vivo.Methods: Male C57BL/6 and farnesoid X receptor knockout (FXR−/−) mice were used to establish the NASH model and were treated with or without geniposide, chlorogenic acid, obeticholic acid (OCA), and antibiotics for assessment of the serum and tissue levels of various biochemical parameters, bile acid, DNA sequencing of bacterial 16S amplicon, protein expression, and histology.Results: The data showed that the combination of geniposide and chlorogenic acid (GC) reduced the levels of blood and liver lipids, serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST), and the liver tissue index in NASH mice. In addition, GC treatment improved the intestinal microbial disorders in the NASH mice as well as the intestinal and serum bile acid metabolism. At the gene level, GC induced FXR signaling, i.e., increased the expression of FXR, small heterodimer partner (SHP), and bile salt export pump (BSEP) in liver tissues and fibroblast growth factor 15 (FGF15) expression in the ileal tissues of NASH mice. However, antibiotics (ampicillin, neomycin, vancomycin, and tinidazole) in drinking water (ADW) reversed the effect of GC on NASH and altered the gut microbiota in NASH mice in vivo. Furthermore, GC treatment failed to improve NASH in the FXR−/− mouse NASH model in vivo, indicating that the effectiveness of GC treatment might be through FXR signaling activation.Conclusion: GC was able to alleviate NASH by improving the gut microbiome and activating FXR signaling; its effect was better than each individual agent alone.https://www.frontiersin.org/articles/10.3389/fphar.2023.1148737/fullNASHmicrobiotabile acidFXRgeniposidechlorogenic acid
spellingShingle Hongshan Li
Hongshan Li
Yingfei Xi
Xin Xin
Qin Feng
Yiyang Hu
Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo
Frontiers in Pharmacology
NASH
microbiota
bile acid
FXR
geniposide
chlorogenic acid
title Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo
title_full Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo
title_fullStr Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo
title_full_unstemmed Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo
title_short Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo
title_sort geniposide plus chlorogenic acid reverses non alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo
topic NASH
microbiota
bile acid
FXR
geniposide
chlorogenic acid
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1148737/full
work_keys_str_mv AT hongshanli geniposidepluschlorogenicacidreversesnonalcoholicsteatohepatitisviaregulationofgutmicrobiotaandbileacidsignalinginamousemodelinvivo
AT hongshanli geniposidepluschlorogenicacidreversesnonalcoholicsteatohepatitisviaregulationofgutmicrobiotaandbileacidsignalinginamousemodelinvivo
AT yingfeixi geniposidepluschlorogenicacidreversesnonalcoholicsteatohepatitisviaregulationofgutmicrobiotaandbileacidsignalinginamousemodelinvivo
AT xinxin geniposidepluschlorogenicacidreversesnonalcoholicsteatohepatitisviaregulationofgutmicrobiotaandbileacidsignalinginamousemodelinvivo
AT qinfeng geniposidepluschlorogenicacidreversesnonalcoholicsteatohepatitisviaregulationofgutmicrobiotaandbileacidsignalinginamousemodelinvivo
AT yiyanghu geniposidepluschlorogenicacidreversesnonalcoholicsteatohepatitisviaregulationofgutmicrobiotaandbileacidsignalinginamousemodelinvivo